RANBAXY SIGNS DEAL WITH CIPHER TO SELL ACNE DRUG
(Indian Business Insight Via Acquire Media NewsEdge) Ranbaxy Laboratories Ltd (RLL) has entered into an agreement with Cipher Pharmaceuticals of Canada for marketing its acne drug isotretinoin capsules in Brazil. This is an extension of an earlier deal between the two companies as per which RLL markets the same medicine under the brand name Absorica in the US. As per the deal RLL will make an upfront payment
to Cipher in addition to certain milestone payment.
[ Back To Technology News's Homepage ]